Advanced Filters
noise

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,220 clinical trials
O Otuwe Anya, BA

Nebulized Ketamine for the Treatment of Major Depressive Disorder

This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.

18 - 88 years of age All Phase 3
S Sara Tremblay, PhD

Comparing the Efficacy of Accelerated vs. Standard fMRI-guided iTBS in Treating Adolescents Depression

Repetitive transcranial magnetic stimulation (rTMS) is a Health Canada approved treatment for major depression. Theta burst stimulation (TBS), a type of rTMS, is a very promising new treatment for major depression in adults and adolescents. However, very few studies have assessed the efficacy of accelerated, three times a day TBS …

16 - 19 years of age All Phase N/A

Non-invasive BCI and Application Verification for Depressed People

Major Depressive Disorder (MDD) is a serious mental illness and public health problem that poses threat to both physical and mental health. According to statistics from WHO, it is estimated that more than 350 million people worldwide suffer from depression, with a prevalence rate of 2.1% in China, which is …

12 years of age All Phase 4
R Rachel Ngan Yin Chan, PhD

Digital Mood-enhanced CBT-I to Improve Depressive Symptoms in Adolescents

Emerging encouraging evidence showed that sleep focused treatment can simultaneously improve sleep and depression in adult with comorbid conditions. Although these favorable changes in depressed adults is encouraging, little is known in the potential efficacy of CBT-I in altering depression trajectory in adolescent population. This current study aims to compare …

12 - 18 years of age All Phase N/A
I Ivan Alfredo Huespe, MD, MPh

Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients

\*\Brief Summary\\* Depressive symptoms are frequent among patients admitted to the intensive care unit (ICU) and may be associated with worse clinical outcomes, reduced participation in care, lower treatment adherence, and increased mortality. Conventional antidepressants, including selective serotonin reuptake inhibitors (SSRIs), have limited utility in this setting because of their …

18 - 99 years of age All Phase 2
M Marie Asp, PhD

Long-term Follow-up of Depressive Disorders in Psychiatric Care

The project investigates long-term prognosis and predictors of treatment outcomes for difficult-to-treat depression in patients in secondary psychiatric care. The current patient cohort was collected in 2012-2021 in the study "Pharmacogenetics in patients with depression with specific focus on difficult-to-treat depression, suicide attempt and CYP2D6". The cohort consists of 415 …

18 years of age All Phase N/A
R Roger S. McIntyre, MD, FRCPC

Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder

This study will look at how a new medication (dextromethorphan and bupropion taken together in one pill) affects the brain in people with depression. All participants will take the medication for two weeks and have brain scans done. Since people with depression often feel reduced enjoyment in day-to-day activities, our …

18 - 65 years of age All Phase 2
G Gyu Hee Lee, HBSc

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

The goal of this clinical trial is to learn if Lemborexant works to treat residual insomnia in adults with depression that is being treated. It will also learn about how practical, tolerable, and effective Lemborexant is. The main questions it aims to answer are: Does Lemborexant help participants improve sleep …

18 - 70 years of age All Phase 2
J Jennifer Goldschmied, PhD

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

In the treatment of Major Depressive Disorder (MDD), ketamine can produce rapid but short-lasting improvements in mood. In order to develop a new generation of treatments with rapid and sustained efficacy, a better understanding of the mechanism of action is urgently needed. One candidate mechanism is the modulation of synaptic …

25 - 65 years of age All Phase 0
L Lindsey Cunnane

Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression

The goal of this clinical trial is to learn how hormonal changes over the menstrual cycle affect mood symptoms in reproductive-aged women with depression that worsens during the premenstrual period. The main questions it aims to answer are: --How do fluctuations in estradiol and progesterone across the menstrual cycle affect …

18 - 45 years of age Female Phase 4

Simplify language using AI